Literature DB >> 1778585

Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men.

Y J Wang1, J C Wu, S D Lee, Y T Tsai, K J Lo.   

Abstract

To investigate the gonadal dysfunction and changes in sex hormones in male patients with postnecrotic cirrhosis, and to compare them with those in alcoholic cirrhotic men, three age-matched groups of men (hepatitis B virus-related postnecrotic cirrhosis 27, alcoholic cirrhosis 21, normal controls 30) were studied. Twelve of the 21 (57%) alcoholic cirrhotics and 16 of the 27 (59%) postnecrotic cirrhotics had a history of impotence. Both alcoholic and postnecrotic cirrhotic patients had significantly lower basal testosterone, but higher estradiol and prolactin levels than the control group (p less than 0.05). However, no differences were noted between the two cirrhotic groups. The degree of reduced testosterone and increased prolactin levels correlated with the severity of the cirrhosis. Despite the low testosterone concentration, basal levels of follicle stimulating hormone (FSH) and luteinizing hormone (LH) were not increased in the cirrhotic patients. All the three groups studied had normal FSH and LH responses to the stimulation of exogenous gonadotropin releasing hormone. On the basis of these results, we conclude that: (1) impotence and low testosterone level are not infrequent findings in men with hepatitis B virus-related postnecrotic cirrhosis, especially in those with decompensated liver function. (2) The liver disease per se is important for the development of male sexual dysfunction. (3) The derangement of hypothalamic-pituitary function may play a role in the sexual dysfunction and changes in sex hormones in male patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1778585

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  26 in total

Review 1.  Osteoporosis in chronic liver disease.

Authors:  J Heathcote
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 2.  Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases.

Authors:  Md Kamruzzaman Munshi; Sally Priester; Eugenio Gaudio; Fuquan Yang; Gianfranco Alpini; Romina Mancinelli; Candace Wise; Fanyn Meng; Antonio Franchitto; Paolo Onori; Shannon S Glaser
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 3.  Male sexual disturbances in liver diseases: what do we know?

Authors:  M Durazzo; A Premoli; C Di Bisceglie; S Bo; E Ghigo; C Manieri
Journal:  J Endocrinol Invest       Date:  2010 Jul-Aug       Impact factor: 4.256

Review 4.  Why are hematopoietic stem cells so 'sexy'? on a search for developmental explanation.

Authors:  M Z Ratajczak
Journal:  Leukemia       Date:  2017-05-15       Impact factor: 11.528

5.  Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.

Authors:  Sergei Mechtcheriakov; Ivo-W Graziadei; André Kugener; Julia Wiedemann; Chantal Galbavy; Hartmann Hinterhuber; Josef Marksteiner; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

6.  Hypogonadism is not related to the etiology of liver cirrhosis.

Authors:  S Kaymakoğlu; A Okten; Y Cakaloğlu; G Boztaş; F Beşişik; C Taşçioğlu; S Yalçin
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

7.  Erectile dysfunction in patients with chronic viral liver disease: its relevance to protein malnutrition.

Authors:  Katsuhisa Toda; Yoshiyuki Miwa; Shoko Kuriyama; Hideki Fukushima; Makoto Shiraki; Nobuo Murakami; Makoto Shimazaki; Yoichiro Ito; Toshiyuki Nakamura; Jun'ichi Sugihara; Eiichi Tomita; Chisato Nagata; Kazutomo Suzuki; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

8.  Increase of hypophyseal hormone levels in male head and neck cancer patients.

Authors:  Eva Remenár; Irén Számel; Barna Budai; Borbála Vincze; István Gaudi; Sarolta Gundy; Miklós Kásler
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

9.  The influence of hepatic function on prostate cancer outcomes after radical prostatectomy.

Authors:  L L Bañez; R M Loftis; S J Freedland; J C Presti; W J Aronson; C L Amling; C J Kane; M K Terris
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-03-02       Impact factor: 5.554

10.  Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1.

Authors:  Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Sharon DeMorrow; Antonio Franchitto; Heather Francis; Shannon Glaser; Guido Carpino; Julie Venter; Domenico Alvaro; Shelley Kopriva; Mellanie White; Ashley Kossie; Jennifer Savage; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-23       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.